These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 32994117)

  • 1. Evaluation of Testing Frequency and Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 Surveillance Strategies in Long-Term Care Facilities.
    Lanièce Delaunay C; Saeed S; Nguyen QD
    J Am Med Dir Assoc; 2020 Nov; 21(11):1574-1576.e2. PubMed ID: 32994117
    [No Abstract]   [Full Text] [Related]  

  • 2. People power: How India is attempting to slow the coronavirus.
    Vaidyanathan G
    Nature; 2020 Apr; 580(7804):442. PubMed ID: 32286539
    [No Abstract]   [Full Text] [Related]  

  • 3. Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2.
    Hogan CA; Sahoo MK; Pinsky BA
    JAMA; 2020 May; 323(19):1967-1969. PubMed ID: 32250394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Privacy in the Coronavirus Era.
    Labs J; Terry S
    Genet Test Mol Biomarkers; 2020 Sep; 24(9):535-536. PubMed ID: 32677850
    [No Abstract]   [Full Text] [Related]  

  • 5. Coronavirus COVID-19 impacts to dentistry and potential salivary diagnosis.
    Sabino-Silva R; Jardim ACG; Siqueira WL
    Clin Oral Investig; 2020 Apr; 24(4):1619-1621. PubMed ID: 32078048
    [No Abstract]   [Full Text] [Related]  

  • 6. Disposition of patients with coronavirus disease 2019 (COVID-19) whose respiratory specimens remain positive for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) by polymerase chain reaction assay (PCR).
    Mermel LA
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1326-1327. PubMed ID: 32517833
    [No Abstract]   [Full Text] [Related]  

  • 7. Special Issue on Diagnostic Testing for Severe Acute Respiratory Syndrome Coronavirus 2 and Lessons from This Pandemic.
    McAdam AJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703896
    [No Abstract]   [Full Text] [Related]  

  • 8. Screening for COVID-19 in Symptomatic Cancer Patients in a Cancer Hospital.
    Fujiwara Y; Sato Y; Wang X; Oikado K; Sato Y; Fukuda N; Enokida T; Takeda K; Ohkushi D; Hayama B; Egi Y; Tokai Y; Yamada Y; Nakajima Y; Kubota M; Haruki S; Shimizu T; Uchida Y; Utsugi K; Ito Y; Ohno S; Takahashi S; Tsuchida T;
    Cancer Cell; 2020 Nov; 38(5):609-610. PubMed ID: 33064994
    [No Abstract]   [Full Text] [Related]  

  • 9. Environmental surface testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during prolonged isolation of an asymptomatic carrier.
    Shin KS; Park HS; Lee J; Lee JK
    Infect Control Hosp Epidemiol; 2020 Nov; 41(11):1328-1330. PubMed ID: 32539889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19: Diagnostic Testing and Challenges.
    Ogbebor O; Min Z; Cheema T; Bhanot N
    Crit Care Nurs Q; 2020; 43(4):343-348. PubMed ID: 32833771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Lung Cancer Patient with Dyspnea: Diagnostic Difficulties during the COVID-19 Pandemic.
    Pruis MA; Hussain B; Bakker M; Hoek RAS; Miedema JR; Dingemans AC; Paats MS
    Cancer Cell; 2020 Nov; 38(5):611-612. PubMed ID: 33068525
    [No Abstract]   [Full Text] [Related]  

  • 12. Selecting a SARS-CoV-2/COVID Molecular Testing Method for Your Laboratory.
    Greene DN
    J Appl Lab Med; 2020 Jul; 5(4):837-840. PubMed ID: 32761155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 surveillance for all newborns at the NICU; conditio sine qua non?
    de Winter JP; De Luca D; Tingay DG
    Eur J Pediatr; 2020 Dec; 179(12):1945-1947. PubMed ID: 32785859
    [No Abstract]   [Full Text] [Related]  

  • 14. My Experience with SARS-CoV-2, with a Focus on Testing.
    Cotter PA
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32703893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. India under COVID-19 lockdown.
    The Lancet
    Lancet; 2020 Apr; 395(10233):1315. PubMed ID: 32334687
    [No Abstract]   [Full Text] [Related]  

  • 16. New evidences that discard the possible vertical transmission of SARS-CoV-2 during pregnancy.
    Hijona Elósegui JJ; Carballo García AL; Fernández Risquez AC
    Med Clin (Barc); 2020 Oct; 155(7):313-314. PubMed ID: 32546318
    [No Abstract]   [Full Text] [Related]  

  • 17. Universal Testing-Based Response to COVID-19 Outbreak by a Long-Term Care and Post-Acute Care Facility.
    Bakaev I; Retalic T; Chen H
    J Am Geriatr Soc; 2020 Jul; 68(7):E38-E39. PubMed ID: 32526802
    [No Abstract]   [Full Text] [Related]  

  • 18. Potential Presymptomatic Transmission of SARS-CoV-2, Zhejiang Province, China, 2020.
    Tong ZD; Tang A; Li KF; Li P; Wang HL; Yi JP; Zhang YL; Yan JB
    Emerg Infect Dis; 2020 May; 26(5):1052-1054. PubMed ID: 32091386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic.
    Stavert R; Meydani-Korb A; de Leon D; Osgood R; Blau J; Luu T
    J Am Acad Dermatol; 2020 Dec; 83(6):1753-1755. PubMed ID: 32822790
    [No Abstract]   [Full Text] [Related]  

  • 20. [Which sampling method for the upper respiratory tract specimen should be taken to diagnose patient with COVID-19?].
    Ye B; Fan C; Pan Y; Ding R; Hu HX; Xiang ML
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2020 Jun; 55(6):583-588. PubMed ID: 32166939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.